2m 2m 2m 2m 2m 2m 2m
SAVARA (SVRA)
NASDAQ
$5.75+$0.06 (+1.02%)
Price as of Jun 23, 2026 7:56 PM EDT- $1.2BMarket Cap
- 163.43%1-Year Change
- BiotechnologyIndustry
SAVARA (SVRA)
$5.75+$0.06 (+1.02%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 0 N/A | 0 N/A | 0 N/A | 0 -100.00% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -81.4M +4.33% | -78.0M +76.29% | -44.3M +58.76% | -27.9M -3.84% | |
Depreciation and Amortization Expense | 87,000 -33.08% | 130,000 +68.83% | 77,000 +148.39% | 31,000 -77.21% | |
Total Operating Expenses | 123.5M +19.72% | 103.2M +71.97% | 60.0M +54.50% | 38.8M -6.36% | |
Operating Profit | -123.5M +19.72% | -103.2M +71.97% | -60.0M +54.50% | -38.8M -6.36% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | -88,000 -96.14% | |
Interest Income and Expense and Net | 0 N/A | 0 N/A | 0 +100.00% | -88,000 -96.14% | |
Total Nonoperating Income and Expense | 4.7M -35.61% | 7.3M +37.78% | 5.3M +670.54% | 689,000 +144.83% | |
Income before Taxes | -123.5M +19.72% | -103.2M +71.97% | -60.0M +54.50% | -38.8M -6.36% | |
Income Taxes | 0 -100.00% | 9,000 N/A | N/A N/A | N/A N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -118.8M +23.94% | -95.9M +75.29% | -54.7M +43.38% | -38.1M -11.31% | |
Net Income from Continuing Operations Applicable to Common | -118.8M +23.94% | -95.9M +75.29% | -54.7M +43.38% | -38.1M -11.31% | |
Basic EPS and Net Income | -0.53 +10.42% | -0.48 +45.45% | -0.33 +32.00% | -0.25 -21.87% | |
Diluted EPS and Net Income | -0.53 +10.42% | -0.48 +45.45% | -0.33 +32.00% | -0.25 -21.87% | |
Basic Weighted Average Shares | 222.4M +12.21% | 198.2M +19.97% | 165.2M +8.14% | 152.8M +14.08% | |
Diluted Weighted Average Shares | 222.4M +12.21% | 198.2M +19.97% | 165.2M +8.14% | 152.8M +14.08% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 33.2M +119.33% | 15.1M -43.10% | 26.6M -48.97% | 52.1M +53.18% | |
Short-Term Investments | 202.5M +11.77% | 181.2M +33.50% | 135.7M +83.98% | 73.8M -41.98% | |
Cash and Cash Equivalents and Short-Term Investments | 235.7M +20.06% | 196.3M +20.95% | 162.3M +28.95% | 125.9M -21.90% | |
Total Current Assets | 241.6M +19.53% | 202.1M +21.81% | 165.9M +28.69% | 129.0M -21.85% | |
Accumulated Depreciation | 2.3M +7.91% | 2.2M +7.46% | 2.0M +4.63% | 1.9M -7.50% | |
Property and Plant and Equipment and Net | 100,000 -39.39% | 165,000 -38.89% | 270,000 +429.41% | 51,000 -30.14% | |
Total Long-Term Assets | 84,000 -65.29% | 242,000 -37.47% | 387,000 +233.62% | 116,000 -53.78% | |
Total Assets | 253.4M +19.05% | 212.9M +19.89% | 177.6M +27.03% | 139.8M -20.85% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 0 N/A | N/A N/A | N/A N/A | 8.3M 0.00% | |
Total Current Liabilities | 20.4M +38.52% | 14.7M +38.94% | 10.6M +80.62% | 5.9M -59.98% | |
Total Long-Term Debt | 29.9M +12.35% | 26.6M +1.03% | 26.3M +1.04% | 26.1M +50.54% | |
Total Long-Term Liabilities | 0 -100.00% | 87,000 -64.78% | 247,000 +357.41% | 54,000 -53.85% | |
Total Liabilities | 50.3M +21.42% | 41.4M +11.39% | 37.2M +16.23% | 32.0M -0.31% | |
Retained Earnings | -608.1M +24.29% | -489.3M +24.37% | -393.4M +16.15% | -338.7M +12.69% | |
Total Stockholders Equity | 203.1M +18.48% | 171.4M +22.14% | 140.4M +30.24% | 107.8M -25.41% | |
Total Shares Outstanding | 204.6M +18.64% | 172.4M +24.81% | 138.1M +21.13% | 114.0M +0.008% | |
Cash Flow | |||||
Cash from Operating Activities | -101.0M +13.41% | -89.1M +74.47% | -51.1M +47.77% | -34.6M -13.79% | |
Capital Expenditures | 22,000 -12.00% | 25,000 -91.55% | 296,000 +3,188.89% | 9,000 -84.21% | |
Cash from Investing Activities | -18.4M -53.83% | -39.9M -30.07% | -57.1M -208.49% | 52.6M +175.80% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 137.8M +17.20% | 117.6M +42.04% | 82.8M +95,049.43% | 87,000 -99.93% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Return on Assets | -50.97% +3.78% | -49.11% +42.47% | -34.47% +42.94% | -24.12% -23.09% | |
Return on Equity | -63.45% +3.18% | -61.50% +39.50% | -44.08% +45.76% | -30.24% -26.56% | |
Revenue Growth | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Current Ratio | 11.85 -13.71% | 13.73 -12.33% | 15.66 -28.75% | 21.98 +95.28% | |
Cash Ratio | 1.63 +58.34% | 1.03 -59.05% | 2.51 -71.75% | 8.88 +282.75% | |
Debt-to-Equity Ratio | 0.15 N/A | N/A N/A | N/A N/A | 0.32 +79.79% | |
Debt-to-Assets Ratio | 0.12 N/A | N/A N/A | N/A N/A | 0.25 +69.44% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow